Structures by: Rietveld I. B.
Total: 11
C20H36N4O14
C20H36N4O14
Annales Pharmaceutiques Francaises (2014) 72, 238-243
a=15.4326(3)Å b=5.20150(10)Å c=16.2067(3)Å
α=90.00° β=91.9860(10)° γ=90.00°
C60,2(CH2BrCl)
C60,2(CH2BrCl)
CrystEngComm (2018) 20, 19 2729
a=10.056(3)Å b=10.056(3)Å c=10.070(2)Å
α=90.0000° β=90.0000° γ=120.000°
C60,2(CH2BrCl)
C60,2(CH2BrCl)
CrystEngComm (2018) 20, 19 2729
a=9.9153(17)Å b=17.412(4)Å c=10.0478(17)Å
α=90.0000° β=101.966(9)° γ=90.0000°
C60,2(C0.50H0.50Br0.50Cl)
C60,2(C0.50H0.50Br0.50Cl)
CrystEngComm (2019) 21, 7 1180
a=10.140(3)Å b=31.233(9)Å c=10.122(3)Å
α=90° β=90.21(2)° γ=90°
C60,2(CHBrCl2)
C60,2(CHBrCl2)
CrystEngComm (2019) 21, 7 1180
a=10.1313(17)Å b=10.1313(17)Å c=10.1351(17)Å
α=90.0000° β=90.0000° γ=120.000°
L tyrosine ethyl ester
C11H15NO3
CrystEngComm (2015) 17, 21 3974
a=12.6554(36)Å b=16.0575(33)Å c=5.2045(12)Å
α=90° β=90° γ=90°
C8H4NO6,C7H7N2
C8H4NO6,C7H7N2
CrystEngComm (2016) 18, 42 8194
a=7.6484(5)Å b=16.6146(11)Å c=11.9576(7)Å
α=90° β=108.1110(10)° γ=90°
Potassium guaiacolsulfonate
C7H7KO5S
Crystal Growth & Design (2013) 13, 7 3028
a=18.8885(23)Å b=6.40793(84)Å c=16.5076(19)Å
α=90° β=96.8851(61)° γ=90°
Potassium guaiacolsulfonate hemihydrate
C7O5H7S1K1,0.5H2O
Crystal Growth & Design (2013) 13, 7 3028
a=19.4360(16)Å b=6.3452(5)Å c=16.2640(14)Å
α=90.00° β=97.1560(10)° γ=90.00°
C6H13N3O3
C6H13N3O3
Crystal Growth & Design (2014) 14, 3 1279
a=14.895(5)Å b=9.852(2)Å c=5.353(2)Å
α=90.00° β=90.00° γ=90.00°
3,4 DAP phosphate
C5H8N3,H2O4P
Crystal Growth & Design (2013) 13, 2 708
a=20.3871(13)Å b=7.7263(2)Å c=14.6064(9)Å
α=90.00° β=128.494(10)° γ=90.00°